August 25, 2016 7:50 AM ET

Pharmaceuticals

Company Overview of Staidson (Beijing) Biopharmaceuticals Co., Ltd.

Company Overview

Staidson (Beijing) Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, distribution, and sale of biological products and chemical drugs in China. The company primarily provides tablets, powders, capsules, injections, and others. Its products include Su peptide Health, an injection for the treatment of optic nerve damage; Shu Taiqing, a polyethylene glycol electrolyte powder, which is applied in the bowel cleansing and used for the treatment of constipation; Gliclazide tablets for type 2 diabetes; and Aspirin, a non-steroidal anti-inflammatory drug. The company also offers Nabumetone capsules for the treatment of acute and chronic inflammatory arthritis, soft tissu...

Beijing Economic and Technological Development Zone

No. 36 Sea Road

Beijing,  100176

China

Founded in 2002

721 Employees

Phone:

86 10 6751 9888

Fax:

86 10 6751 9794

Key Executives for Staidson (Beijing) Biopharmaceuticals Co., Ltd.

Staidson (Beijing) Biopharmaceuticals Co., Ltd. does not have any Key Executives recorded.

Staidson (Beijing) Biopharmaceuticals Co., Ltd. Key Developments

Staidson (Beijing) Biopharmaceuticals Co., Ltd. to Report First Half, 2016 Results on Aug 23, 2016

Staidson (Beijing) Biopharmaceuticals Co., Ltd. announced that they will report first half, 2016 results on Aug 23, 2016

Staidson (Beijing) Biopharmaceuticals Co., Ltd. Approves Amendments to the Articles of Association

Staidson (Beijing) Biopharmaceuticals Co., Ltd. announced that at its Extraordinary General Meeting held on July 07, 2016, the company approved the amendments to the company's articles of association.

Staidson (Beijing) Biopharmaceuticals Co., Ltd. Proposes Amendments to the Articles of Association

Staidson (Beijing) Biopharmaceuticals Co., Ltd. has proposed amendments to the articles of association of the company at the EGM to be held on July 7, 2016.

Recent Private Companies Transactions

Type
Date
Target
Private Placement
July 18, 2016
InflaRx GmbH
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Staidson (Beijing) Biopharmaceuticals Co., Ltd., please visit www.staidson.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.